Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
RVAC Medicines announces research collaboration with University of Pennsylvania mRNA Vaccine Pioneer 2023-03-17 21:00
Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion 2023-03-17 19:25
Sisram Medical Ltd. to Announce Full Year 2022 Financial Results on March 21, 2023 2023-03-17 19:04
Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results 2023-03-17 18:43
WATERDROP ANNOUNCES CERTAIN BOARD AND EXECUTIVE CHANGES 2023-03-17 18:35
SYMBYX announces promising Sydney Adventist Hospital clinical trial results for Parkinson's using the SYMBYX Neuro - a new light therapy wellness helmet 2023-03-17 18:30
China's first personalized neoantigen-targeted cancer vaccine receives NMPA's clinical trial approval 2023-03-17 14:56
UnionTech Showcases Dental 3D Printer S300+ at IDS 2023, International Dental Show in Cologne, Germany 2023-03-17 10:34
GCCL Develops PBMC Resource Management System 2023-03-17 09:26
AXA Study: 1 out of 5 people in Hong Kong feel they are flourishing 2023-03-17 09:12
YS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQ 2023-03-17 04:30
Oral Care Brand Bitvae Celebrates World Oral Health Day With a Collection of High-Quality, Easy-to-Use Products Accessible to All 2023-03-16 22:20
Nav1.7 Selective Inhibitor OLP-1002 Shows Strong Efficacy and Long Therapeutic Duration according to Interim Findings from a Phase 2a Study in OA Patients 2023-03-16 21:00
FDA Approves Expanded Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Directed Radioligand Therapy 2023-03-16 20:28
Angel Yeast Showcases Latest Product Innovations at Food Ingredients China 2023 2023-03-16 20:16
TurtleTree debuts first-ever animal-free lactoferrin—one of milk’s most valuable and functional proteins—in world-first tasting 2023-03-16 20:00
Bolstering Healthcare Quality in Malaysia with Renowned Flagship Hospitals 2023-03-16 16:12
The FDA has approved the CSF-1R inhibitor Pimicotinib (ABSK021) of Abbisko Therapeutics to enter the Pivotal Global Multi-center Phase III Clinical Trial 2023-03-16 10:00
Alphamab Oncology Announces the First Patient Dosed in the Phase I Trial of Anti-HER2 bispecific ADC JSKN003 2023-03-16 09:58
FDA Approves Expanded Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Directed Radioligand Therapy 2023-03-16 08:28
1 256 257 258 259 260 1594